Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer

被引：0
|
作者：
Hyo Jin Lee
Do Yeun Cho
Ji Chan Park
Sang Byung Bae
Kyu Taek Lee
In Sung Cho
Chang Soon Han
Suk Young Park
Hwan Jung Yun
Samyong Kim
机构：
[1] Chungnam National University Hospital,Division of Hematology/Oncology, Department of Internal Medicine
[2] Konyang University Hospital,Department of Internal Medicine
[3] Daejeon St. Mary’s Hospital,Department of Internal Medicine
[4] Soon Chun Hyang University Cheonan Hospital,Department of Internal Medicine
[5] Eulji University Hospital,Department of Internal Medicine
[6] Cheongju St. Mary’s Hospital,Department of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Gastric cancer; Paclitaxel; 5-Fluorouracil; Leucovorin; Biweekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial)
    Kotake, Masanori
    Aoyama, Toru
    Munemoto, Yoshinori
    Doden, Kenji
    Kataoka, Masato
    Kobayashi, Kenji
    Nishimura, Genichi
    Fujita, Hidehito
    Nakamura, Keishi
    Takehara, Akira
    Tanaka, Chihiro
    Sakamot, Junichi
    NagatA', Naoki
    Oba, Koji
    Kondo, Ken
    ONCOLOGY LETTERS, 2017, 13 (02) : 747 - 753
  • [32] Randomized phase II trial of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) for advanced gastric cancer
    Shin, D.
    Lee, S.
    Park, S.
    Park, J.
    Cho, E.
    Lee, J.
    Lee, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma
    Lee, J.
    Kang, W. K.
    Kwon, J. M.
    Oh, S. Y.
    Lee, H. R.
    Kim, H. J.
    Park, B. B.
    Lim, H. Y.
    Han, M. J.
    Park, J. O.
    Park, Y. S.
    ANNALS OF ONCOLOGY, 2007, 18 (01) : 88 - 92
  • [34] Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: Results of a phase II study
    Klaassen, U
    Wilke, H
    Muller, C
    Borquez, D
    Harstrick, A
    Seeber, S
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 58 - 60
  • [35] A Phase II Study of 5-Fluorouracil/Leucovorin in Combination with Paclitaxel and Oxaliplatin as First-Line Treatment for Patients with Advanced Gastric Cancer
    Lin, Rong-Bo
    Fan, Nan-Feng
    Guo, Zeng-Qing
    Wang, Xiao-Jie
    Liu, Jie
    Chen, Ling
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (06) : 744 - 748
  • [36] A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer
    Kim, R
    Murakami, S
    Ohi, Y
    Inoue, H
    Yoshida, K
    Toge, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (05) : 921 - 926
  • [37] Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: A Vanderbilt cancer center phase II trial
    Nicholson, B
    Paul, D
    Shyr, Y
    Garrett, M
    Hande, KR
    Johnson, DH
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 20 - 23
  • [38] Salvage chemotherapy with biweekly irinotecan, plus 5-fluorouracil and leucovorin in patients with advanced gastric cancer previously treated with fluoropyrimidine, platinum, and taxane
    Sym, Sun Jin
    R-Yu, Min-Hee
    Lee, Jae-Lyun
    Chang, Heung Moon
    Kim, Tae Won
    Lee, Sting Sook
    Lee, Jung Shin
    Kang, Yoon-Koo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 151 - 156
  • [39] Phase II multicenter trial of a weekly paclitaxel, 5-fluorouracil and leucovorin regimen in patients with metastatic breast cancer
    Loesch, DM
    Robert, NJ
    Keller, AM
    Young, JA
    Rohrbaugh, TM
    Smyth, AC
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 32 - 32
  • [40] A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma
    M. Raida
    R. Kath
    M. Arnrich
    G. Kähler
    J. Scheele
    K. Höffken
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 335 - 340
12345